4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000004
Options or other derivatives
- Chief Commercial Officer acquired 161,108 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Milanova Tsveta · Chief Commercial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-03 | Grant or award : show line 1 in the form Stock option (right to buy) | +135,682 | 135,682 | D |
| 2023-01-03 | Grant or award : show line 2 in the form Restricted stock units | +25,426 | 25,426 | D |
Loading xslF345X03/wf-form4_167295304325378.xml…